In the context of pancreatic ductal adenocarcinoma (PDAC), the TGF-β pathway is one of only four signaling pathways that is genetically altered (with at least one mutation) in 100% of PDAC18. The gene discussed is TGFB1; the disease is pancreatic ductal adenocarcinoma.